Frontpage » Tag » pfizer

News tagged with pfizer

Study reveals how the world's first drug for amyloid disease works

Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel) works. Tafamidis, approved for use in Europe and currently under ...

Medical research created May 29, 2012 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Faulty gene connected to ovarian cancer risk

In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expect ...

Cancer created Aug 09, 2011 | popularity not rated yet | comments 0 | with audio podcast report

Bristol-Myers, Pfizer's Eliquis approved in Japan

Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...

Medications created Dec 26, 2012 | popularity not rated yet | comments 0

Genetic differences may influence sensitivity to pain, study finds

The study, published in PLOS Genetics on 20 December, adds to growing evidence that particular genes are involved in chronic pain and highlights this pathway as a potential target for more effective pain relief treatments for pa ...

Genetics created Dec 20, 2012 | popularity 5 / 5 (1) | comments 1 | with audio podcast

MicroRNA-218 targets medulloblastoma, most aggressive childhood brain cancer

Between the blueprint of the genome and the products of its expression lie microRNAs, which can boost or lower the rate at which genes become stuff. In fact, many cancers use microRNA to magnify the expression of faulty genes ...

Cancer created Dec 13, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Canada high court voids Pfizer's Viagra patent

Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.

Medications created Nov 08, 2012 | popularity not rated yet | comments 0

Some gains but many mysteries as Alzheimer's epidemic looms

More than 100 years after it was first caught in the act of decaying a patient's brain, Alzheimer's remains one of medicine's greatest challenges as it robs ever more people of their memory and independence.

Alzheimer's disease & dementia created Sep 17, 2012 | popularity not rated yet | comments 1

Studies: Alzheimer drug may stabilize brain plaque (Update)

An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.

Alzheimer's disease & dementia created Sep 11, 2012 | popularity not rated yet | comments 0

Alzheimer's drug fails in 1 study, 2nd continues (Update)

(AP) — A closely watched experimental Alzheimer's treatment has failed to slow the disease in one late-stage study, a big disappointment for doctors and patients but not the end of the road for the drug. Pfizer Inc. ...

Alzheimer's disease & dementia created Jul 23, 2012 | popularity not rated yet | comments 0

Alzheimer's drug sharply criticized by medical experts

Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company and approved by the Food ...

Alzheimer's disease & dementia created Mar 23, 2012 | popularity 5 / 5 (1) | comments 0

Coffee, caffeine not linked to psoriasis in U.S. women

(HealthDay) -- Coffee and caffeine are not associated with psoriasis incidence after adjustment for smoking, according to a research letter published in the March issue of the Archives of Dermatology.

Diseases, Conditions, Syndromes created Mar 21, 2012 | popularity not rated yet | comments 1 | with audio podcast

Clinical study of epilepsy drug may have been purely promotional

Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according ...

Medications created Jun 27, 2011 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Antibody-guided drug works against acute lymphoblastic leukemia

An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be ...

Cancer created May 23, 2011 | popularity 5 / 5 (1) | comments 0 | with audio podcast

n-3 fatty acids no benefit for high-risk cardio patients

(HealthDay)—For patients with multiple cardiovascular risk factors or atherosclerotic vascular disease who have not had a myocardial infarction, daily treatment with n-3 fatty acids does not reduce cardiovascular ...

Cardiology created May 09, 2013 | popularity not rated yet | comments 0

Bashful? Buy the little blue pill online (Update)

Pfizer Inc., in a first for the drug industry, told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra directly to patients on its website.

Medications created May 06, 2013 | popularity not rated yet | comments 0

Pfizer

Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), antibiotic Zithromax (azithromycin), Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).

Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.

On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.

For more information about Pfizer, read the full article at Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.